ePrivacy and GPDR Cookie Consent by TermsFeed Generator

Detail of the clinical trial

Title of the trial An evaluation of the effectiveness and tolerability of tapentadol hydrochloride prolonged release, and tapentadol hydrochloride immediate release on demand, in subjects with severe chronic nociceptive, mixed or neuropathic low back pain taking WHO step III analgesics but showing a lack of tolerability
EudraCT number 2009-010428-25
Protocol number KF5503/45
Sponsor Grunenthal GmbH, Germany
Indications Pain disorders
Diagnosis severe chronic nociceptive, mixed or neuropathic low back pain
Population in clinical trial Adults (18-65 years)
Elderly ( > 65 years)
Male
Female
Patients
Year of receiving the request to Institute (SÚKL) 2009
Date of approval by Institute (SÚKL) 15.2.2010
Date of approval by EC 18.1.2010
Date of initiation CT in ČR 22.3.2010
Date of ending CT in ČR 11.3.2011
Notice
Sites Centrum bolesti, FN U sv. Anny, Brno
Centrum bolesti, FN Olomouc
Centrum bolesti, FN Ostrava

‹‹ Back to list